Nintedanib Ethanesulfonate Salt For Treatment of idiopathic pulmonary fibrosis CAS number 656247-18-6

Payment Type: L/C,T/T
Incoterm: FOB
Min. Order: 1 Kilogram
Delivery Time: 15 Days

Basic Info

Model No.:  656247-18-6

Additional Info

Packaging: AS REQUIRED

Productivity: KGS


Transportation: Air

Place of Origin: CHINA


Certificate: ISO

Product Description

Nintedanib Ethanesulfonate Salt CAS number is 656247-18-6 is an oral triple-acting vascular kinase inhibitor developed by Boehringer Ingelheim and was approved by the FDA in October 2014 for the treatment of idiopathic pulmonary fibrosis (IPF), becoming the first tyrosine kinase inhibitor (TKI) approved for the treatment of IPF. Nintedanib Ethanesulfonate Salt has been shown to act on growth factors ,It has potential effects on the pathophysiology of pulmonary fibrosis, the most important of which is the platelet-derived growth factor receptor (PDGFR) Fibroblast growth factor receptor (FGFR) and vascular endothelial growth factor receptor (VEGFR); by blocking these signal transduction pathways involved in fibrosis progression,Nintedanib Ethanesulfonate slowed down by slowing the rate of decline in lung function IPF disease progression. In addition, Nintedanib Ethanesulfonate cas 656247-18-6 has been found to be useful in the treatment of many cancers, including non-small cell lung cancer, prostate cancer, ovarian cancer, and colorectal cancer.
At present, the quality standard of Nintedanib Ethanesulfonate is not included in the domestic and foreign pharmacopoeia, and no reports about the determination of the impurity have been reported at home and abroad. According to the guideline "limit of genotoxic impurities released by the European Pharmacopoeia Administration (EMEA) Principles ", according to Toxicological Toxicity Threshold (TTC) as the threshold for the evaluation of most genotoxic impurities, the maximum limit of genotoxic impurities intake is 1.5μg / g. A daily recommended dose of 300 mg is included in the Nintedanib Ethanesulfonate instruction.

Thera. Category:  Anti-cancer

Cas No.:  656247-18-6

Synonym: Nintedanib ethanesulfonate;BIBF 1120 esylate;BIBF-1120 esylate;Nintedanib esylate;Nintedanib ethanesulfonate salt;BIBF1120/nintedanib ethanesulfonate salt;Trinidad Neeb esylate


Molecular Weight:  649.75706

Molecular formula: C31H33N5O4.C2H6O3S

Assay: ≥98.%

Appearance: White Crystalline solid

Packing:Export worthy packing

Material Safety Data Sheet:Available on request

Active Pharmaceutical Ingredients> Cas 90098-04-7,Rebamipide Named In Mucosta With GMP Standard
Active Pharmaceutical Ingredients> Functional Dyspepsia Treatment Acotiamide Hydrochloride Trihydrate CAS 773092-05-0
Active Pharmaceutical Ingredients> Acotiamide Hydrochloride For Gastric Motility Improvement CAS 185104-11-4
Contract Manufacturing> ASCORBYL GLUCOSIDE Used for Comesitc Additive CAS 129499-78-1
Pharmaceutical Intermediates> Anti-Ulcerative> 2-Aminothiazole-4-ethylformate For Making Acotiamide Cas 5398-36-7
Pharmaceutical Intermediates> Anti-Ulcerative> Acotiamide INT CAS NUMBER 185105-98-0
Pharmaceutical Intermediates> Anti-Cardiovascular> Azilsartan Used for Hypertension Treatment CAS 147403-03-0
Pharmaceutical Intermediates> Anti-Diabetes> Sitagliptin Phosphate Monohydrate Treated for Type 2 diabetes CAS Number 654671-77-9
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 132210-24-3, 2-Amino-3-(1,2-dihydro-2-oxo-quinoline-4-yl)Propanoic acid Hydrochloride For Rebamipide
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 1068-90-2 White Crystalline Powder Diethyl Acetamidomalonate For Rebamipide(DAAM)
Active Pharmaceutical Ingredients> 6027-23-2, Hordenine HCL Powder
Pharmaceutical Intermediates> Anti-Ulcerative> Cas 4876-10-2,4-Bromomethyl-2(1H)-quinolinone (BMQ) For Rebamipide/ Mucosta
Pharmaceutical Intermediates> Anti-Respiratory> CAS 2338-18-3, 2-Aminoindan hydrochloride For Making Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> CAS 312753-53-0/ 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Used for Indacaterol
Pharmaceutical Intermediates> Anti-Respiratory> 312753-53-0, Indacaterol Intermediate
Pharmaceutical Intermediates> Anti-Respiratory> 100331-89-3, Indacaterol Intermediate

© 2019 CHINA WAY. All Rights Reserved.  Taizhou Volsen Chemical Co., Ltd.,  Inc.   All rights reserved. site map.  sitemap.html